Cargando…
Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production
Terrein is a fungal metabolite and has been known to exert anti-melanogenesis, anti-cancer, and anti-bacterial activities. However, its role in endotoxemia has never been investigated until now. In the present study, we examined the effect of terrein on lipopolysaccharide (LPS)-induced endotoxemia i...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693353/ https://www.ncbi.nlm.nih.gov/pubmed/36422559 http://dx.doi.org/10.3390/ph15111429 |
_version_ | 1784837519725035520 |
---|---|
author | Yoon, Yeo Dae Lee, Myeong Youl Choi, Byeong Jo Lee, Chang Woo Lee, Hyunju Kwon, Joo-Hee Yang, Jeong-Wook Kang, Jong Soon |
author_facet | Yoon, Yeo Dae Lee, Myeong Youl Choi, Byeong Jo Lee, Chang Woo Lee, Hyunju Kwon, Joo-Hee Yang, Jeong-Wook Kang, Jong Soon |
author_sort | Yoon, Yeo Dae |
collection | PubMed |
description | Terrein is a fungal metabolite and has been known to exert anti-melanogenesis, anti-cancer, and anti-bacterial activities. However, its role in endotoxemia has never been investigated until now. In the present study, we examined the effect of terrein on lipopolysaccharide (LPS)-induced endotoxemia in mice and characterized the potential mechanisms of action. Treatment with terrein increased the survival of mice and decreased the production of inflammatory cytokines, including interleukin-1β (IL-1β) and interleukin-6 (IL-6) in an LPS-induced endotoxemia model. In addition, terrein suppressed the LPS-induced production of IL-1β and IL-6 in RAW 264.7 cells, a murine macrophage-like cell line, and the mRNA expression of IL-1β and IL-6 was also inhibited by terrein in LPS-stimulated RAW 264.7 cells. Further study demonstrated that terrein blocked LPS-induced phosphorylation of p65 subunit of nuclear factor (NF)/κB and the phosphorylation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) was also suppressed by terrein treatment. Collectively, these results suggest that terrein exerts a protective effect again LPS-induced endotoxemia in mice by blocking the production of inflammatory cytokines. Our results also suggest that the anti-inflammatory effect of terrein might be mediated, at least in part, by blocking the activation of NF-κB, JNK, and p38 MAPK signaling pathways. |
format | Online Article Text |
id | pubmed-9693353 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-96933532022-11-26 Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production Yoon, Yeo Dae Lee, Myeong Youl Choi, Byeong Jo Lee, Chang Woo Lee, Hyunju Kwon, Joo-Hee Yang, Jeong-Wook Kang, Jong Soon Pharmaceuticals (Basel) Article Terrein is a fungal metabolite and has been known to exert anti-melanogenesis, anti-cancer, and anti-bacterial activities. However, its role in endotoxemia has never been investigated until now. In the present study, we examined the effect of terrein on lipopolysaccharide (LPS)-induced endotoxemia in mice and characterized the potential mechanisms of action. Treatment with terrein increased the survival of mice and decreased the production of inflammatory cytokines, including interleukin-1β (IL-1β) and interleukin-6 (IL-6) in an LPS-induced endotoxemia model. In addition, terrein suppressed the LPS-induced production of IL-1β and IL-6 in RAW 264.7 cells, a murine macrophage-like cell line, and the mRNA expression of IL-1β and IL-6 was also inhibited by terrein in LPS-stimulated RAW 264.7 cells. Further study demonstrated that terrein blocked LPS-induced phosphorylation of p65 subunit of nuclear factor (NF)/κB and the phosphorylation of c-Jun N-terminal kinase (JNK) and p38 mitogen-activated protein kinase (MAPK) was also suppressed by terrein treatment. Collectively, these results suggest that terrein exerts a protective effect again LPS-induced endotoxemia in mice by blocking the production of inflammatory cytokines. Our results also suggest that the anti-inflammatory effect of terrein might be mediated, at least in part, by blocking the activation of NF-κB, JNK, and p38 MAPK signaling pathways. MDPI 2022-11-18 /pmc/articles/PMC9693353/ /pubmed/36422559 http://dx.doi.org/10.3390/ph15111429 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yoon, Yeo Dae Lee, Myeong Youl Choi, Byeong Jo Lee, Chang Woo Lee, Hyunju Kwon, Joo-Hee Yang, Jeong-Wook Kang, Jong Soon Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title | Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title_full | Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title_fullStr | Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title_full_unstemmed | Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title_short | Protection against Lipopolysaccharide-Induced Endotoxemia by Terrein Is Mediated by Blocking Interleukin-1β and Interleukin-6 Production |
title_sort | protection against lipopolysaccharide-induced endotoxemia by terrein is mediated by blocking interleukin-1β and interleukin-6 production |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9693353/ https://www.ncbi.nlm.nih.gov/pubmed/36422559 http://dx.doi.org/10.3390/ph15111429 |
work_keys_str_mv | AT yoonyeodae protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT leemyeongyoul protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT choibyeongjo protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT leechangwoo protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT leehyunju protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT kwonjoohee protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT yangjeongwook protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production AT kangjongsoon protectionagainstlipopolysaccharideinducedendotoxemiabyterreinismediatedbyblockinginterleukin1bandinterleukin6production |